Skip to main content
Loading
Kazu Matsuda

Kazu Matsuda

Multi-Indication Radiosensitizing Platform to enhance Radiotherapy & Immunotherapy Effectiveness, Kortuc
United States
Kazu Matsdua is a serial entrepreneur with a successful exit track record. Prior to this, he started off as a biotech investment banker at Mitsubishi and Merril Lynch. He studied Economics at University of Tokyo and earned and MBA at INSEAD (France, Abu Dhabi, Singapore).
Sessions

BIO DOUBLE HELIX SPONSOR

BIO HELIX SPONSOR

CONFERENCE SPONSORS